Report of Independent Registered Public Accounting Firm
To the Board of Trustees of and Shareholders of Allianz Variable
 Insurance Products Fund of Funds Trust
In planning and performing our audits of the financial
statements of each of the funds constituting Allianz Variable
Insurance Products Fund of Funds Trust (as listed in Appendix A
and hereafter referred to collectively as the 'Funds') as of and
 for the year ended December 31, 2021, in accordance with the
standards of the Public Company Accounting Oversight Board
(United States) (PCAOB), we considered the Funds' internal
control over financial reporting, including controls over
safeguarding securities, as a basis for designing our auditing
procedures for the purpose of expressing our opinion on the
financial statements and to comply with the requirements of Form
 N-CEN, but not for the purpose of expressing an opinion on the
effectiveness of the Funds' internal control over financial
reporting.  Accordingly, we do not express an opinion on the
effectiveness of the Funds' internal control over financial
reporting. The management of the Funds is responsible for
establishing and maintaining effective internal control over
financial reporting. In fulfilling this responsibility,
estimates and judgments by management are required to assess the
 expected benefits and related costs of controls. A fund's
internal control over financial reporting is a process designed
to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted
accounting principles. A fund's internal control over financial
reporting includes those policies and procedures that (1)
pertain to the maintenance of records that, in reasonable detail,
 accurately and fairly reflect the transactions and dispositions
 of the assets of the fund; (2) provide reasonable assurance
that transactions are recorded as necessary to permit preparation
 of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the
fund are being made only in accordance with authorizations of
management and trustees of the fund; and (3) provide reasonable
assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of a fund's assets
that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists
 when the design or operation of a control does not allow
management or employees, in the normal course of performing
their assigned functions, to prevent or detect misstatements on
a timely basis. A material weakness is a deficiency, or a
combination of deficiencies, in internal control over financial
reporting, such that there is a reasonable possibility that a
material misstatement of the Funds' annual or interim financial
statements will not be prevented or detected on a timely basis.
Our consideration of the Funds' internal control over financial
reporting was for the limited purpose described in the first
paragraph and would not necessarily disclose all deficiencies in
 internal control over financial reporting that might be material
 weaknesses under standards established by the PCAOB. However, we
 noted no deficiencies in the Funds' internal control over
financial reporting and their operation, including controls over
 safeguarding securities, that we consider to be material
weaknesses as defined above as of December 31, 2021.
This report is intended solely for the information and use of the
 Board of Trustees of Allianz Variable Insurance Products Fund
of Funds Trust and the Securities and Exchange Commission and is
 not intended to be and should not be used by anyone other than
these specified parties.
/s/PricewaterhouseCoopers LLP
February 24, 2022
APPENDIX A
AZL Balanced Index Strategy Fund
AZL DFA Multi-Strategy Fund
AZL MVP Balanced Index Strategy Fund
AZL MVP Global Balanced Index Strategy Fund
AZL MVP DFA Multi-Strategy Fund
AZL MVP Fusion Balanced Fund
AZL MVP Fusion Conservative Fund
AZL MVP Fusion Moderate Fund
AZL MVP Growth Index Strategy Fund
AZL MVP Moderate Index Strategy Fund
AZL MVP Fidelity Institutional Asset Management Multi-Strategy
Fund
AZL MVP T. Rowe Price Capital Appreciation Plus Fund